Retrospective Analysis of Serum Parameters in Patients Treated With Check-Point Inhibitors in 2AND Line for Advance Non-small-Cell Lung Cancer

被引：0
|
作者：
Paco, Pablo Flores [1 ,2 ]
Moreno, Alberto [1 ,2 ]
Barneto, Isidoro [1 ,2 ]
Sanchez, Pedro [1 ,2 ]
Vargas, Alicia [1 ,2 ]
Guevara, Geraldina [1 ,2 ]
Lopez-Herrero, Maria [1 ,2 ]
Aranda, Enrique [1 ,2 ]
机构：
[1] Univ Reina Sofia, Cordoba, Spain
[2] Inst Maimonides Invest Biomed Cordoba, Cordoba, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.43
引用
收藏
页码：S25 / S26
页数：2
相关论文
共 50 条
  • [41] Costs and values of the immune check point inhibitors antibodies in non-small cell lung cancer
    Guirgis, Helmy M.
    Langer, Corey J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Extensive serum biomarker analysis in patients with non-small-cell lung carcinoma
    Cai, Donghao
    Xu, Ying
    Ding, Rui
    Qiu, Kaifeng
    Zhang, Ruihua
    Wang, Han
    Huang, Lisi
    Xie, Xiaoying
    Yan, Haiyan
    Deng, Yawen
    Lin, Xianghua
    Shao, Jing
    Luo, Xiaohong
    Duan, Chaohui
    CYTOKINE, 2020, 126
  • [43] Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study
    Yang, Xiongwen
    Xiao, Yi
    Zhou, Yubin
    Deng, Huiyin
    Yuan, Zihao
    Dong, Longyan
    Lan, Jun
    Hu, Hao
    Huang, Jian
    Huang, Shaohong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [44] First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with ImmuneCheckpoint Inhibitors
    Bylicki, Olivier
    Barazzutti, Helene
    Paleiron, Nicolas
    Margery, Jacques
    Assie, Jean-Baptiste
    Chouaid, Christos
    BIODRUGS, 2019, 33 (02) : 159 - 171
  • [45] Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
    Kim, Jung Han
    Kim, Hyeong Su
    Kim, Bum Jun
    ONCOTARGET, 2017, 8 (54) : 93149 - 93155
  • [46] Lung cavitation in lung metastases of gastric and non-small-cell lung cancer patients treated with apatinib
    Cecere, Fabiana Letizia
    Aguilar, Andres
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (04) : 317 - 318
  • [47] Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab
    Inoue, Takako
    Tamiya, Motohiro
    Tamiya, Akihiro
    Nakahama, Kenji
    Taniguchi, Yoshihiko
    Shiroyama, Takayuki
    Isa, Shin-ichi
    Nishino, Kazumi
    Kumagai, Toru
    Kunimasa, Kei
    Kimura, Madoka
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Atagi, Shinji
    Imamura, Fumio
    CLINICAL LUNG CANCER, 2018, 19 (02) : E171 - E176
  • [48] Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
    Chen, Hao
    Chong, Wei
    Wu, Qian
    Yao, Yueliang
    Mao, Min
    Wang, Xin
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [49] Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients
    Gobbini, Elisa
    Toffart, Anne Claire
    Perol, Maurice
    Assie, Jean-Baptiste
    Duruisseaux, Michael
    Coupez, Dahna
    Dubos, Catherine
    Westeel, Virginie
    Delaunay, Myriam
    Guisier, Florian
    Veillon, Remi
    Gounant, Valerie
    Leprieur, Etienne Giroux
    Vanel, Francois-Roger
    Chaabane, Nouha
    Dansin, Eric
    Babey, Helene
    Decroisette, Chantal
    Barlesi, Fabrice
    Daniel, Catherine
    Fournel, Pierre
    Mezquita, Laura
    Oulkhouir, Youssef
    Canellas, Anthony
    Duchemann, Boris
    Molinier, Olivier
    Alcazer, Vincent
    Moro-Sibilot, Denis
    Levra, Matteo Giaj
    CLINICAL LUNG CANCER, 2020, 21 (05) : E497 - E510
  • [50] Meta-analysis of the incidence and risks of interstitial lung disease and QTc prolongation in non-small-cell lung cancer patients treated with ALK inhibitors
    Lin, Liping
    Zhao, Juanjuan
    Kong, Ning
    He, Yan
    Hu, Jiazhu
    Huang, Fuxi
    Han, Jianjun
    Cao, Xiaolong
    ONCOTARGET, 2017, 8 (34) : 57379 - 57385
12345